[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $aplif $APLIF sees increased social activity amidst market fluctuations, with engagements up XXX% from the previous month. Appili secures $40M in NIAID funding for vaccine development, driving social engagement around the project's cryptocurrency $APLIF. ### About $aplif A cryptocurrency project. ### Engagements: XX [#](/topic/$aplif/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$aplif/time-series/interactions.tsv) **Current Value**: XX **Daily Average**: XXX **1 Week**: XXX -XX% **1 Month**: XXX +360% **1-Year High**: XXXXX on 2025-06-26 **1-Year Low**: X on 2025-07-10 | Social Network | X | | -------------- | - | | Engagements | XX | ### Mentions: X [#](/topic/$aplif/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$aplif/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: X **1 Month**: X -XX% **1-Year High**: XX on 2025-07-19 **1-Year Low**: X on 2025-06-15 | Social Network | X | | -------------- | - | | Mentions | X | ### Creators: X [#](/topic/$aplif/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$aplif/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $aplif in the last XX hours which is no change from in the previous XX hours **Daily Average**: X **1 Month**: X no change **1-Year High**: X on 2025-07-19 **1-Year Low**: X on 2025-04-27 **Top assets mentioned** In the posts about $aplif in the last XX hours [BOLT Token (BOLT)](/topic/bolt-token) **Top topics mentioned** In the posts about $aplif in the last XX hours [$evax](/topic/$evax), [$pali](/topic/$pali), [$anro](/topic/$anro), [$ovid](/topic/$ovid), [bolt token](/topic/bolt-token) ### Top Social Posts [#](/topic/$aplif/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$EVAX will present new biomarker and immune data for its personalized cancer vaccine EVX-01 in advanced melanoma at SITC 2025 complementing upcoming two-year efficacy results from its Phase X KEYTRUDA combination trial being presented at ESMO 2025. $PALI $ANRO $OVID $IMAB $BOLT $EVAX $APLIF $CLNN $SPRC $OCEA See More Biotech Updates👇" [X Link](https://x.com/BPharmCatalyst/status/1974210485022085549) [@BPharmCatalyst](/creator/x/BPharmCatalyst) 2025-10-03T20:30Z 30.4K followers, 3429 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$APLIF sees increased social activity amidst market fluctuations, with engagements up XXX% from the previous month. Appili secures $40M in NIAID funding for vaccine development, driving social engagement around the project's cryptocurrency $APLIF.
A cryptocurrency project.
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Week: XXX -XX%
1 Month: XXX +360%
1-Year High: XXXXX on 2025-06-26
1-Year Low: X on 2025-07-10
Social Network | X |
---|---|
Engagements | XX |
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1 Month: X -XX%
1-Year High: XX on 2025-07-19
1-Year Low: X on 2025-06-15
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $aplif in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1 Month: X no change
1-Year High: X on 2025-07-19
1-Year Low: X on 2025-04-27
Top assets mentioned In the posts about $aplif in the last XX hours
Top topics mentioned In the posts about $aplif in the last XX hours
$evax, $pali, $anro, $ovid, bolt token
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$EVAX will present new biomarker and immune data for its personalized cancer vaccine EVX-01 in advanced melanoma at SITC 2025 complementing upcoming two-year efficacy results from its Phase X KEYTRUDA combination trial being presented at ESMO 2025. $PALI $ANRO $OVID $IMAB $BOLT $EVAX $APLIF $CLNN $SPRC $OCEA See More Biotech Updates👇"
X Link @BPharmCatalyst 2025-10-03T20:30Z 30.4K followers, 3429 engagements
/topic/$aplif